Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.21
-0.03-1.34%
At close: Jan 21, 4:00 PM EST
$2.25
0.04011.81%
After Hours: 7:50 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Invivyd (IVVD) stock?
You can purchase shares of Invivyd (NASDAQ:IVVD) through any online brokerage.
Who are Invivyd (IVVD) competitors?
Other companies in Invivyd’s space includes: Gyre Therapeutics Inc (NASDAQ:GYRE), Replimune Group Inc (NASDAQ:REPL), MapLight Therapeutics Inc (NASDAQ:MPLT), Kyverna Therapeutics Inc (NASDAQ:KYTX) and Cullinan Therapeutics Inc (NASDAQ:CGEM).
What is the forecast, or price target, for Invivyd (IVVD) stock?
Invivyd has a consensus price target of $6.84.
What is the current price for Invivyd (IVVD)?
The stock price for Invivyd (NASDAQ: IVVD) is $2.2501 last updated January 21, 2026 at 7:50 PM EST.
Does Invivyd (IVVD) pay a dividend?
There are no upcoming dividends for Invivyd.
When is Invivyd (NASDAQ:IVVD) reporting earnings?
Invivyd does not have any upcoming earnings scheduled.
Is Invivyd (IVVD) going to split?
There is no upcoming split for Invivyd.
What sector and industry does Invivyd (IVVD) operate in?
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
